The latest price target for Orthofix Medical (NASDAQ:OFIX) was reported by Canaccord Genuity on January 22, 2025. The analyst firm set a price target for $24.00 expecting OFIX to rise to within 12 months (a possible 30.51% upside). 6 analyst firms have reported ratings in the last year.

The latest analyst rating for Orthofix Medical (NASDAQ:OFIX) was provided by Canaccord Genuity, and Orthofix Medical initiated their buy rating.

The last upgrade for Orthofix Medical Inc happened on November 8, 2024 when Stifel raised their price target to $24. Stifel previously had a hold for Orthofix Medical Inc.

The last downgrade for Orthofix Medical Inc happened on September 12, 2023 when BTIG changed their price target from N/A to N/A for Orthofix Medical Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Orthofix Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Orthofix Medical was filed on January 22, 2025 so you should expect the next rating to be made available sometime around January 22, 2026.

While ratings are subjective and will change, the latest Orthofix Medical (OFIX) rating was a initiated with a price target of $0.00 to $24.00. The current price Orthofix Medical (OFIX) is trading at is $18.39, which is within the analyst’s predicted range.